The IMPULSE Study: Pilot "IMPULSE"


Phase N/A Results N/A

Summary of Purpose

Continuous-flow (CF) left ventricular assist devices (LVADs) are an important tool in the treatment of end-stage heart failure, affording patients significantly improved quantity and quality of life. In recent years, tens of thousands of LVADs have been implanted worldwide, with nearly 1,000 at the Texas Heart Institute (THI). Despite the benefits from LVAD therapy, one major weakness is the high frequency of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 April 2017.

1 Aug 2014 21 Jan 2014 1 Apr 2016 1 Dec 2016 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Crossover Assignment